Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Skyhawk Therapeutics
Skyhawk Therapeutics
Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D
Fierce Biotech
Mon, 04/22/24 - 11:32 am
Ipsen
Skyhawk Therapeutics
RNA modulation
R&D
Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify
BioPharma Dive
Tue, 12/22/20 - 11:29 pm
Vertex Pharmaceuticals
Skyhawk Therapeutics
small molecule drugs
M&A
Merck doubles down on Skyhawk's tech to drug RNA, promising $600M per autoimmune, metabolic target
Endpoints
Tue, 05/12/20 - 11:55 am
Merck
Skyhawk Therapeutics
small molecule drugs
RNA
R&D
Roche's Genentech goes on deal spree, unveiling third deal on the same day
Endpoints
Tue, 07/16/19 - 10:57 am
Roche
Genentech
Sosei Heptares
Skyhawk Therapeutics
Convelo Therapeutics
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
Biogen stock trends up on neurology disease deals
Biopharma Dive
Tue, 01/8/19 - 11:38 pm
Biogen
C4 Therapeutics
Skyhawk Therapeutics
Pair of deals boosts Biogen’s early-stage CNS pipeline
Pharmaforum
Mon, 01/7/19 - 11:20 am
Biogen
CNS
Alzheimer's disease
MS
C4 Therapeutics
Skyhawk Therapeutics